Jubilant Pharmova is a multifaceted pharma player, standing amidst a blend of growth and transformation. While some its segments are showing robust growth ...
As the market anticipates a potential rate cut by RBI in the near future, InvITs & REITs as an asset class are well-positioned to benefit. With that in mind, ...
Looks like InvITs have hit a bit of a rough patch recently. But hey, every cloud has a silver lining, right? Could this dip in price be a buying opportunity? ...
In this post, we try to answer one key question for the 'cautiously optimistic' investor: Yes, small-cap stocks are frothy, but by how much? We analyzed the ...
With ongoing capacity expansion and strategic moves into new territories, Varun Beverages is positioning itself to capture increased market share and enter new ...
There are hundreds of smallcases to choose from. Each month brings a new list of smallcases showing great short-term returns. But that's not how you should ...
Over the last decade, the Indian chemical industry has distinguished itself as a global leader in terms of growth and creating shareholder value. The chemical ...
KSB Ltd., a leading manufacturer of pumps and valves, is well-positioned to leverage India’s growing infrastructure investments. Despite appearing as a ...
The RBI, often the silent architect of our financial landscape, has made strategic manoeuvres that reshape the terrain for banks, non-banking financial ...
If you want to zero in on which ELSS fund to invest in for 2024, your search should end here. Find out the best ELSS Fund to invest in to save tax through 80C ...
